Aug 4 (Reuters) - Resverlogix Corp RVX.TO :
* International clinical steering committee announced for resverlogix's phase 3
betonmace clinical trial with rvx-208 "apabetalone"
* Says betonmace is expected to start in the fall of 2015
* Source text for Eikon ID:nPn9nxCW
* Further company coverage RVX.TO